Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure

BACKGROUND: This study aimed to investigate the clinical utility of different soluble suppression of tumorigenicity 2 (sST2) levels in assessing the severity and prognosis of patients with acute heart failure (AHF). METHODS: This was a prospective cohort study. Three hundred and thirty-one consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zeyu, Pan, Xin, Xu, Hong, Wu, You, Jia, Xiaomin, Fang, Yiling, Lu, Yi, Xu, Yawei, Zhang, Ji, Su, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863653/
https://www.ncbi.nlm.nih.gov/pubmed/35224046
http://dx.doi.org/10.3389/fcvm.2022.812654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863653/
https://www.ncbi.nlm.nih.gov/pubmed/35224046
http://dx.doi.org/10.3389/fcvm.2022.812654

Ejemplares similares